Glenmark Pharmaceuticals is banking on global rollout of specialty respiratory drug Ryaltris, making its US-based innovation unit Ichnos self-sustaining through more licensing deals, and expansion of branded formulation business in India, to help...
Like many other industries in the pharmaceutical industry the pandemic suddenly made enterprises to operate differently. For example, all the in-person meetings became virtual.
The Indian pharma industry is expected to grow to $130 billion by 2030 and become the leading provider of medicines to the world, said Indian Pharmaceutical Alliance (IPA) Secretary General...
Singapore granted interim authorisation for a bivalent COVID-19 booster vaccine made by Moderna, the government said in a statement...
Pfizer Inc said it had started a late-stage U.S. trial of an influenza vaccine involving 25,000 patients, among the first such studies for a messenger RNA flu shot...
Prices of several anti-diabetes drugs, patented antivirals used in the treatment of tuberculosis, HIV and hepatitis C are set to get cheaper with their inclusion in the latest edition of National List of Essential Medicines, 2022...
Drug maker Lupin said its biosimilar product Rymti, indicated for the treatment of arthritis, has received approval from the Canadian health authority. The firm's product is the biosimilar of the reference drug Enbrel...
Piramal Pharma, the recently spun-off unit of Piramal Enterprises, is set to raise $225 million in offshore loans as the drugmaker looks to improve its financial metrics ahead of its impending listing as an independent company, people familiar with..
Hyderabad-based firm Bharat Biotech has sought permission from the drug regulator to conduct phase-3 study of its intranasal COVID-19 vaccine in the 5 to 18 age group. On September 6, the Drugs Controller General of India (DCGI) had approved...
Wearable technology in healthcare is growing rapidly with several advanced features which are expected to offer significant advantages for pharma enterprises